NEW YORK, Dec. 24, 2015 /PRNewswire/ -- This BCC Research report provides detailed market, technology and industry analyses to help readers quantify and qualify the market for drugs used in the treatment of the major skin diseases. Important trends are identified and sales forecasts by product categories and major country markets are provided through 2020.
Use this report to:
Assess and quantify current trends in the global dermatology market in the context of size and growth.
Evaluate global market trends for drugs used in the treatment of major skin diseases.
Gain insight into ongoing research into improved treatment modalities, especially those utilizing biological approaches.
Identify long-standing and emerging companies through profiles and an update on M&A activity.
The global market for skin disease treatment technologies reached $16.4 billion in 2014 and $17.1 billion in 2015. The market should reach $20.4 billion in 2020, demonstrating a compound annual growth rate (CAGR) of 3.6% from 2015 to 2020.
The U.S market for skin disease treatment dominates the global market throughout the period, and totaled $7.3 billion in 2014. The market should reach $7.5 billion in 2015 and $8.6 billion in 2020 at a CAGR of 2.6% from 2015 to 2020.
BRIC (Brazil, Russia, India, China) is the fastest growing region of the global dermatology market with a CAGR of 6% from 2015 to 2020. The market totaled $3.5 billion in 2015 and should reach more than $4.6 billion by 2020.
STUDY GOALS AND OBJECTIVES
The aim of this report is to provide detailed market, technology and industry analyses to help readers quantify and qualify the market for drugs used in the treatment of the major skin diseases. Special emphasis is given to ongoing research into improved treatment modalities, especially those utilizing biological approaches. Important trends are identified and sales forecasts by product categories and major country markets are provided through 2020; these are based on epidemiological data and projections plus information on R&D trends and their likely effects on market potential on a country-by-country basis.
REASONS FOR DOING THE STUDY
The dermatology market is facing a period of change after several years during which it was a relatively modest and slow-growing sector within the overall pharmaceutical environment. The advent of innovative therapies for some skin diseases has been a stimulus for renewed interest in this market among major pharma companies. New contenders in this market have emerged as small- to medium-size companies evolve into medium to large concerns by a process of serial acquisitions. In this environment, there is a need for an up-to-date and comprehensive appraisal of the dermatology marketplace, with a review of the most important diseases, portfolios and pipelines.
SCOPE OF REPORT
This report discusses the implications of the above-mentioned trends in the context of the current size and growth of the dermatology market, discussed both in global terms and in reference to the most important national markets. Long-standing and emerging companies are discussed, with profiles of their leadership and an update on M&A activity. Five-year global sales forecasts are provided for main drug categories, and breakdowns are provided for several national markets.
Read the full report: http://www.reportlinker.com/p01351952-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001